Stem Cell Authority Stock Net Asset
| SCAL Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stem Cell Authority, as well as the relationship between them.
Stem Cell's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Stem Cell's valuation are provided below:Stem Cell Authority does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Stem |
Stem Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stem Cell's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stem Cell.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in Stem Cell on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Stem Cell Authority or generate 0.0% return on investment in Stem Cell over 90 days. Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of ste... More
Stem Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stem Cell's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stem Cell Authority upside and downside potential and time the market with a certain degree of confidence.
Stem Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stem Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stem Cell's standard deviation. In reality, there are many statistical measures that can use Stem Cell historical prices to predict the future Stem Cell's volatility.Stem Cell Authority Backtested Returns
We have found three technical indicators for Stem Cell Authority, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Stem Cell are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Stem Cell Authority has perfect predictability. Overlapping area represents the amount of predictability between Stem Cell time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stem Cell Authority price movement. The serial correlation of 1.0 indicates that 100.0% of current Stem Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Stem Cell Authority has a Net Asset of 3.99 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The net asset for all United States stocks is notably lower than that of the firm.
Stem Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stem Cell's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Stem Cell could also be used in its relative valuation, which is a method of valuing Stem Cell by comparing valuation metrics of similar companies.Stem Cell is currently under evaluation in net asset category among its peers.
Stem Fundamentals
| Return On Asset | 0.49 | |||
| Profit Margin | 0.55 % | |||
| Operating Margin | 0.55 % | |||
| Current Valuation | 9.15 M | |||
| Shares Outstanding | 348.71 M | |||
| Price To Earning | 2.00 X | |||
| Price To Sales | 1.05 X | |||
| Revenue | 3.33 M | |||
| Gross Profit | 2.27 M | |||
| Net Income | 1.83 M | |||
| Cash And Equivalents | 39.84 K | |||
| Total Debt | 675.1 K | |||
| Debt To Equity | 4.88 % | |||
| Current Ratio | 1.12 X | |||
| Earnings Per Share | 0.01 X | |||
| Beta | -71.45 | |||
| Market Capitalization | 2.34 M | |||
| Total Asset | 3.99 M | |||
| Z Score | 1.8 | |||
| Net Asset | 3.99 M |
About Stem Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stem Cell Authority's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stem Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stem Cell Authority based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Stem Pink Sheet
Stem Cell financial ratios help investors to determine whether Stem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Cell security.